Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Vildan Kayku Liv Hospital Bahçeşehir Spec. MD. Vildan Kayku Medical Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Low FDG Tumors: Why Some Cancers Are Hard to Detect on PET Scans
Low FDG Tumors: Why Some Cancers Are Hard to Detect on PET Scans 4

After a PET scan, many wonder why they must stay away from others. A PET scan uses a radioactive tracer, like FDG, to check for health issues, like cancer.

Those with low FDG tumors worry about the tracer not being absorbed well. This could make the scan less accurate. The tracer’s radioactive nature also raises radiation safety concerns. So, patients are told to avoid being around pregnant women and kids to reduce radiation exposure.

Key Takeaways

  • PET scans involve radioactive tracers that require safety precautions.
  • Patients with low FDG tumors may have specific concerns related to tracer absorption.
  • Radiation safety guidelines are in place to protect others from exposure.
  • Isolation after a PET scan is key to reducing radiation exposure.
  • Following post-PET scan instructions is vital for patient and public safety.

The Science Behind PET Scans

Low FDG Tumors: Why Some Cancers Are Hard to Detect on PET Scans
Low FDG Tumors: Why Some Cancers Are Hard to Detect on PET Scans 5

PET scans have changed nuclear medicine a lot. They give deep insights into how our bodies work. This method uses energy from a radioactive tracer to see inside us.

What is a PET scan?

A PET scan is a special imaging tool. It helps find and treat diseases, like cancer. It uses a tiny bit of radioactive material, called a radiotracer, injected into the body.

How radioactive tracers work in the body

Radioactive tracers send out positrons. These positrons meet electrons in our bodies, making gamma rays. The PET scanner catches these rays, showing us what’s inside.

Common applications in disease diagnosis

PET scans are key in fighting cancer. They help doctors see how the disease is growing. They also check the heart and brain for problems.

ApplicationDescription
OncologyCancer diagnosis, staging, and treatment monitoring
CardiologyAssessing heart function and viability
NeurologyStudying brain disorders and neurodegenerative diseases

PET scans are very useful in medicine. They help doctors find and treat diseases better. Knowing how they work helps doctors give better care.

Radioactive Tracers: FDG and Beyond

Radioactive tracers have changed how we do PET scans. These tracers give off radiation that the PET scanner picks up. This helps make detailed pictures of what’s inside our bodies.

Understanding FDG (fluorodeoxyglucose)

FDG is the top choice for PET scans. It’s a special glucose molecule with a radioactive fluorine-18 atom. Cancer cells, which use a lot of glucose, take up more FDG. This lets doctors see tumors and other high-glucose areas.

How tracers emit radiation

Tracers like FDG give off radiation as they decay. FDG’s fluorine-18 atom sends out positrons. These positrons meet electrons and turn into gamma rays. The PET scanner catches these rays.

Decay patterns and half-life considerations

The half-life of a tracer is how long it takes for half to decay. Fluorine-18’s half-life is about 110 minutes. Knowing this helps plan PET scans and understand the images better.

TracerHalf-lifePrimary Use
FDG (Fluorine-18)110 minutesCancer diagnosis, metabolic studies
Rubidium-821.27 minutesMyocardial perfusion imaging
Oxygen-152.04 minutesBrain and tumor studies

Each tracer has its own half-life and use.Each tracer has a specific half-life and application; the choice depends on diagnostic goals and tracer characteristics.

Post-Scan Radiation Emission

Low FDG Tumors: Why Some Cancers Are Hard to Detect on PET Scans
Low FDG Tumors: Why Some Cancers Are Hard to Detect on PET Scans 6

Knowing how long radiation stays after a PET scan is key for safety. After a PET scan, the body gives off radiation because of the tracer used. This is important for patient safety and peace of mind.

Duration of Radioactivity

The time a patient stays radioactive depends on the tracer type and amount. The tracer fluorodeoxyglucose (FDG) has a short half-life. This means it breaks down quickly.

Most patients see their radiation levels drop a lot within a few hours after the scan. It’s important to follow the advice of healthcare professionals to avoid exposing others to radiation.

Measuring Radiation Levels

There are ways to check radiation levels after a PET scan. Tools like Geiger counters can measure this. These tools help figure out when it’s safe for a patient to be around others.

Influencing Factors

Several things can change how fast radiation leaves the body. These include:

  • Hydration levels: Drinking lots of water helps get rid of the tracer.
  • Metabolic rate: People with a faster metabolism might clear the tracer faster.
  • Overall health: Some health conditions can affect how the body handles the tracer.

By knowing these factors and following post-scan advice, patients can reduce their radiation exposure. This ensures a safe recovery for everyone.

Radiation Safety Protocols After PET Scans

Keeping everyone safe is key after a PET scan. There are rules to protect patients and those around them. These rules help keep radiation levels low and make sure everyone is safe.

Standard Isolation Requirements

After a PET scan, patients must follow certain rules. They should stay away from pregnant women and kids. This is to keep them safe from radiation.

“The American College of Radiology states that patients should maintain a safe distance from others for a certain period after the scan”. This shows how important it is to stay isolated.

Duration of Precautionary Measures

How long patients need to follow these rules changes. It depends on the type and amount of radioactive tracer used. Usually, the tracer goes away fast, and patients get clear instructions right after the scan.

Hospital vs. Outpatient Guidelines

Hospitals and clinics have their own rules for safety. Inpatients stay in special rooms to keep radiation away. Outpatients get specific advice for home, like drinking lots of water and staying away from others for a bit.

By following these rules, patients help keep others safe. Medical teams stress that

“Radiation safety is everyone’s responsibility, and following these protocols is key for everyone’s health.”

Protecting Others from Radiation Exposure

It’s important for patients who have had a PET scan to know about secondary radiation exposure. This is when others might get exposed to radiation near someone who has had a PET scan.

The Concept of Secondary Radiation Exposure

During a PET scan, a patient gets a radioactive tracer, oftenFDG (fluorodeoxyglucose). This tracer goes to active areas in the body, like tumors, and sends out positrons. These positrons meet electrons, creating gamma rays that the PET scanner uses to make images. But, these gamma rays can also go outside the body, possibly exposing others to radiation.

To lower the risk of secondary radiation, distance and time are key. The radiation weakens with distance, thanks to the inverse square law. This means the closer you are to the patient, the more radiation you might get.

Distance and Time Considerations

The time a patient is radioactive is also important. The radioactive tracer loses strength over time, making exposure risk lower. For example, Fluorine-18, used in FDG, has a half-life of about 110 minutes. This means its radiation halves every 110 minutes. So, the risk of radiation exposure to others drops quickly over a few hours.

Regulatory Requirements for Patient Release

Groups like theNuclear Regulatory Commission (NRC) in the U.S. set rules to keep patients safe after nuclear medicine tests, like PET scans. These rules often tell patients how far to stay from others, like pregnant women and kids, for a certain time.

GuidelineDescriptionRecommendation
DistanceMaintain a safe distance from othersStay at least 3 feet away from others, specially children and pregnant women
TimeLimit close contactAvoid close contact for at least 4-6 hours post-scan
HygienePractice good hygieneFlush toilet twice after use and wash hands thoroughly

By following these guidelines, patients can help keep those around them safe from radiation. This makes sure everyone stays safe and healthy.

Low FDG Tumors: Detection Challenges

Low FDG tumors are hard to find because they don’t take up much glucose. This makes them tricky to spot with PET scans.

Definition and Characteristics

These tumors don’t take up much fluorodeoxyglucose (FDG), a sugar used in PET scans. This makes them hard to see, making diagnosis tough.

These tumors can be different, but they often have low metabolic rates. This is because they are low-grade malignancies or have specific types.

Why Some Cancers Show Minimal Glucose Uptake

Some cancers don’t take up much glucose because of their biology. For example, some tumors have slower glucose metabolism. This makes them hard to find with FDG-PET.

“The variability in FDG uptake among different tumor types poses a significant challenge for PET imaging, as it can lead to false negatives in cancers with low metabolic activity.”

Journal of Nuclear Medicine

Impact on Diagnostic Accuracy

PET scans are less accurate when dealing with low FDG tumors. These tumors don’t take up FDG well, so they can be missed. This can lead to delayed diagnosis and affect treatment plans.

Tumor TypeFDG UptakeDetection Difficulty
Low-grade MalignanciesLowHigh
High-grade MalignanciesHighLow
Specific Histological SubtypesVariableModerate

Types of Cancer with Low FDG Uptake

Certain cancers are hard to spot with FDG PET scans because they don’t use much energy. This makes it tough to find the cancer. PET scans work by looking at how active cells are.

Common Low-Metabolic Activity Malignancies

Some cancers, like prostate cancer, don’t show up well on FDG PET scans. This is because they don’t use much energy. Other cancers, like neuroendocrine tumors, might be better seen with different scans.

Neuroendocrine tumors can be tricky to spot because they don’t always show up on FDG scans. 68Ga-DOTATATE scans might work better for them. Mucinous adenocarcinomas also don’t show up well because they’re full of mucin.

Histological Features Affecting FDG Avidity

The look of a tumor affects how it shows up on PET scans. Tumors with few cells and lots of mucin don’t use much glucose. This makes them harder to see.

How well a tumor is formed also matters. Well-formed tumors use less energy than those that aren’t as formed. Knowing this helps doctors understand PET scan results better.

Prognostic Implications of Low Uptake

Tumors that don’t use much energy might have a better outlook. This is because they might not grow as fast. But finding these tumors is tricky.

Doctors need to use many ways to find these tumors. They also need to think carefully about what the scans mean. A study said, “The different ways tumors show up on scans means we need to find the best way to look at each one.”

“The different ways tumors show up on scans means we need to find the best way to look at each one.”

Radiation Risk vs. Diagnostic Benefit

PET scans are very useful for diagnosis but they also expose you to radiation. This means we need to think carefully about the benefits and risks. The radiation from PET scans might raise your cancer risk. So, it’s important to know how much radiation you get and compare it to the natural background radiation.

Quantifying Radiation Exposure from PET

The amount of radiation from a PET scan depends on the tracer and the scan type. For example, a F-FDG PET scan usually gives about 7-10 mSv of effective dose.

Comparison to Natural Background Radiation

The average yearly background radiation in the U.S. is 3.1 mSv. So, a PET scan is like getting 2-3 years of background radiation in one go.

Radiation SourceEffective Dose (mSv)
Annual Background Radiation3.1
Typical F-FDG PET Scan7-10

Long-term Risk Assessment

Looking at long-term risks means considering your age, how much radiation you get, and how you might react to it. Even though the risk is low, doctors must think about these risks and benefits when they suggest PET scans.

Contraindications for PET Imaging

Some medical conditions and factors can make PET imaging not suitable or need special care. It’s key to know these contraindications for patient safety and scan success.

Medical Conditions that Preclude Scanning

Some health issues can stop a patient from getting a PET scan. For example, severe claustrophobia can make staying in the scanner hard. Also, patients with certain metal implants or pacemakers might need special steps or other imaging methods.

ConditionConsideration
Severe ClaustrophobiaMay require sedation or alternative imaging
Metal ImplantsMay need to be checked for compatibility with PET scan
PacemakersRequires checking the device’s compatibility and potentially adjusting its settings

Medication Interactions and Concerns

Some medicines can mess with PET scan results. For instance, diabetes medications that change blood sugar levels can affect the scan’s accuracy. It’s vital for patients to tell their healthcare provider about any medicines they’re taking.

When to Reschedule Your Appointment

If a patient has certain conditions or is taking medicines that could mess with the PET scan, they might need to reschedule. Guidelines usually say to reschedule if a patient has:

  • Consumed caffeine or nicotine recently before the scan
  • Taken certain medications that could change the scan results
  • Had a recent infection or inflammation that could affect the scan’s meaning

By knowing these contraindications and taking the right steps, patients can safely get PET imaging and get accurate results.

The Impact of Blood Glucose on PET Results

Blood glucose levels can greatly affect the accuracy of PET scan results. High levels, or hyperglycemia, can make PET scans less clear, mainly when using FDG (fluorodeoxyglucose). This is because FDG and glucose compete for cell uptake.

Hyperglycemia and Scan Quality

High blood sugar can lower FDG uptake in tumors. This might lead to scans that are not clear or accurate. It’s a big issue for people with diabetes, whose blood sugar can change a lot. Keeping blood sugar in check is key for a good scan.

Diabetes Management Before Imaging

For those with diabetes, managing their condition is vital before a PET scan. They might need to adjust their meds, watch their blood sugar, and eat certain foods. Keeping blood sugar right is important for a good scan.

Fasting Requirements and Preparation

Fasting is often needed before a PET scan to keep blood sugar low. How long you fast can vary, but it’s usually a few hours. Here’s what you need to know:

Preparation StepGuideline
Fasting Duration4-6 hours
Blood Glucose MonitoringCheck levels before scan
Medication AdjustmentAs advised by doctor

By following these steps, patients can help make sure their PET scan is as accurate as it can be.

Recent Surgery and Inflammatory Responses

Recent surgery can change how PET scans are read because of the body’s inflammatory response. After surgery, the body starts to heal, which includes inflammation. This inflammation can make PET scans show up differently, as it can look like both healing tissues and cancer.

Impact of Healing Tissue on PET Scan Interpretation

The inflammation from surgery can make the PET scan show more activity. This can make it hard for doctors to tell if it’s cancer or not. It’s important to know when the PET scan is done after surgery to get the right results.

Recommended Waiting Periods After Surgical Procedures

To avoid mistakes in PET scan results, waiting a bit after surgery is often advised. The wait time depends on the surgery type and how fast the body heals. Usually, doctors suggest waiting 4 to 6 weeks, but it varies.

Distinguishing Inflammation from Malignancy

Telling the difference between surgery inflammation and real cancer is a big challenge. Doctors use advanced imaging and look at the patient’s history to figure it out. The table below shows some key differences.

CharacteristicsInflammationMalignancy
PET Scan Uptake PatternDiffuse uptake around the surgical siteFocal uptake in tumor areas
Clinical ContextRecent surgery, wound healingKnown cancer, metastasis
Temporal ChangesDecreases over time as healing progressesPersists or increases over time

Knowing these differences helps doctors make better diagnoses and treatment plans.

Small Lesion Detection Limitations

Small lesion detection is key in PET imaging, but it faces resolution constraints. Being able to spot small lesions is vital for accurate diagnosis and treatment plans.

Technological Constraints

Today’s PET scan tech has limits in resolution, impacting its ability to find small lesions. The scanner’s hardware and software set its resolution.

Resolution constraints in PET scans cause partial volume effects. This spreads out the signal from small lesions, making them harder to spot. This is a big problem in oncology, where finding small tumors early is critical.

Size Thresholds for Reliable Detection

There’s a size limit below which PET scans struggle to detect lesions reliably. This limit changes based on the scanner and its use.

Research shows that lesions under 5-7 mm are often missed due to resolution and sensitivity limits. But, new scanner tech is pushing these limits higher.

Lesion Size (mm)Detection Reliability (%)
5-760
8-1080
>1095

Combining Imaging Modalities

To beat PET scan limits in finding small lesions, mixing imaging types works well. MRI and CT scans add valuable info that boosts accuracy.

Using info from various imaging methods helps doctors better find and understand small lesions. This leads to better care for patients.

Managing Radiation Exposure in Healthcare Settings

Healthcare facilities must take strong steps to manage radiation exposure. This protects staff, patients, and the environment. It’s key to have good radiation safety plans to lower risks from medical tests and treatments.

Protocols for Medical Staff

Medical staff are key in keeping everyone safe from radiation. They follow these steps:

  • They get regular training on how to handle radiation safely.
  • They wear personal protective equipment (PPE) during procedures.
  • They check their radiation exposure with dosimeters.

The National Council on Radiation Protection and Measurements (NCRP) says, “Radiation safety training is vital for all who work with radiation in medicine.”

Facility Design Considerations

The design of healthcare buildings is very important for safety. Here are some key points:

Design ElementPurpose
Shielding in walls and doorsTo cut down radiation exposure in other areas
Controlled access zonesTo keep exposure to those who should be there
Radiation therapy roomsThey have special safety features to reduce exposure during treatment

Monitoring and Documentation Requirements

Keeping track of radiation and documenting it is very important. This means:

  1. Checking radiation levels in the environment often
  2. Keeping records of how much radiation patients get
  3. Tracking how much radiation staff get

By following these steps, healthcare places can keep everyone safe. The American College of Radiology says, “A detailed radiation safety plan is key to reducing exposure and ensuring top-notch care for patients.”

Conclusion: Balancing Safety and Diagnostic Needs

PET scans are key in finding and managing diseases, but they do involve radiation. It’s important to find a balance between keeping patients safe and getting the needed information.

Keeping radiation exposure low is a top priority. This includes protecting patients, doctors, and others. Knowing how PET scans work helps doctors take the right steps to keep everyone safe.

Doctors must think about the risks of radiation when deciding to use PET scans. By using the right protocols and following safety rules, they can get the most information while keeping risks low.

It’s all about finding the right balance for each patient. By focusing on safety and getting accurate results, doctors can give the best care possible.

FAQ

What is a PET scan and how does it work?

A PET scan is a test that uses a radioactive tracer to see how the body works. It injects a small amount of radioactive material into the body. This material is then absorbed by cells.

Why is isolation necessary after a PET scan?

Isolation is needed after a PET scan because the tracer stays in the body and emits radiation. This radiation can be detected by others. To protect others, patients must follow safety protocols, including staying isolated for a while.

How long do patients remain radioactive after a PET scan?

The time a patient stays radioactive after a PET scan varies. It depends on the tracer used and how fast the body breaks it down. Usually, patients stop emitting significant radiation a few hours to a day after the scan.

What are low FDG tumors, and why are they challenging to detect?

Low FDG tumors are cancers that don’t take up much glucose. This makes them hard to spot with FDG-PET scans. They might have low activity or other traits that reduce their glucose uptake. This requires other imaging methods or special diagnostic steps.

Can PET scans be used for all types of cancer?

PET scans are useful for many cancers but not all. They work best for cancers that take up a lot of glucose. For cancers with low glucose uptake, other imaging methods might be needed.

How does hyperglycemia affect PET scan results?

High blood sugar can lower the accuracy of PET scans. This is because it reduces the glucose uptake in tumors. People with diabetes or high blood sugar should manage their levels before a PET scan for the best results.

What are the contraindications for PET imaging?

Some conditions make PET imaging unsafe, like pregnancy or breastfeeding. Certain medications can also affect the scan’s safety or accuracy. It’s important to talk to your doctor about your medical history and any concerns before a PET scan.

How can radiation exposure from PET scans be minimized?

To reduce radiation exposure from PET scans, follow safety protocols like staying isolated for a while. Healthcare providers also use safe dosing and scanning techniques to protect staff and others.

Are there alternative imaging modalities for detecting low FDG tumors?

Yes, other imaging methods like MRI or CT scans can help find low FDG tumors. The right choice depends on the cancer type and the patient’s situation. This shows the importance of a personalized approach to diagnosis.

What are the benefits and limitations of PET scans in cancer diagnosis?

PET scans are very sensitive and specific for cancer diagnosis. They show metabolic activity. But, they might not work for all tumors, like those with low glucose uptake. This means other imaging methods might be needed for a complete picture.

References

  • Flavell, R. R., Naeger, D. M., Aparici, C. M., Hawkins, R. A., Pampaloni, M. H., & Behr, S. C. (2016). Malignancies with low fluorodeoxyglucose uptake at PET/CT: Pitfalls and prognostic importance. Radiographics / PMC. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC4801421/
  • Aldousari, H., Abuhadi, N., Izz, M., Alshammari, T., Ali, Z., Aldaas, R., Bakry, A. E. H., & Abukonna, A. (2023). Assessment of external radiation dose rate after 18F-FDG PET/CT examination. Egyptian Journal of Radiology and Nuclear Medicine, 54, Article 80. Retrieved from https://ejrnm.springeropen.com/articles/10.1186/s43055-023-01031-y
  • Berberoglu, K., Ozudogru, E., Fikri, B., & Oral, A. (2019). External radiation exposure rate after 18F-FDG PET/CT: Radioprotection study. Radioprotection / External radiation exposure rate after 18F-FDG PET/CT. Retrieved from https://www.radioprotection.org/articles/radiopro/full_html/2019/02/radiopro190004/radiopro190004.html
i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Vildan Kayku Medical Oncology

Spec. MD. Vildan Kayku

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 174 28 17